Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in ...

Dr Gabriela Kramer-Marek’s group uses cutting-edge biomedical imaging techniques to gain information about the way particular genes drive cancer progression. Our group’s long-term goal is to develop ...

"Search" is our twice-yearly newsletter to supporters. In our 50th edition of the Autumn Search issue, we look at the latest research news featuring a new breast cancer drug approval in the UK, for ...

Kate Wilson was diagnosed with advanced ovarian cancer at the age of 43 and discovered she was carrying a BRCA gene mutation. She was prescribed a targeted drug called olaparib and five years on the ...

Our group's aim is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma. The goal of our laboratory is to improve the treatment and survival of ...

The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend that the targeted drug olaparib can be used for locally advanced or metastatic breast cancer. The ...

The Breast Cancer Now Toby Robins Research Centre at the ICR receives funding from the charity Breast Cancer Now, and was opened in 1999 by Breast Cancer Now's Patron, HRH The Prince of Wales. The ...

Selene joined the ICR in January 2024 as a Laboratory Technician apprentice in the Structural Chemistry team. During Selene’s time at the ICR, she has learnt many things about chemistry and how to run ...